Activation of Endothelial Cell Mitogen Activated Protein Kinase ERK_1/2 by Extracellular HIV-1 Tat Protein

References

• Albini A., Soldi R., Giunciuglio D., Giraudo E., Benelli R., Primo L., Noonan D. M., Salio M., Camussi G., Rockl W., Bussolino F. The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nature Medicine 1996; 2: 1371–1375
   PubMed Web of Science ®Google Scholar
• Albini A., Ferrini S., Benelli R., Sforzini S., Giunciuglio D., Aluigi M. G., Proudfoot A. E.I., Alouani S., Wells T. N.C., Mariani G., Rabin R. L., Farber J. M., Noonan D. M. HIV-1 Tat protein mimicry of chemokines. Proceedings of the National Academy of Sciences U.S.A. 1998; 95: 13153–13158
   PubMed Web of Science ®Google Scholar
• Barillari G., Gendelman R., Gallo R. C., Ensoli B. The Tat protein of human immunodeficency virus type I, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proceedings of the National Academy of Sciences U.S.A. 1993; 90: 7941–7945
   PubMed Web of Science ®Google Scholar
• Corallini A., Campioni D., Rossi C., Albini A., Possati L., Rusnati M., Gazzanelli G., Benelli R., Masiello L., Sparacciari V., Presta M., Mannello F., Fomanini G., Barbanti-Brodano G. Promotion of tumor metastases and induction of angiogenesis by native HIV-1 Tat protein from Bk virus/tat transgenic mice. AIDS 1996; 10: 701–710
   PubMed Web of Science ®Google Scholar
• Dewhurst S., Gelbard H. A., Fine S. M. Neuropathogenesis of AIDS. Molecular Medicine Today January, 1996; 16–23
   PubMedGoogle Scholar
• Eliceri B. P., Klemke R., Stromblad S., Cheresh D. A. Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. Journal of Cell Biology 1998; 140: 1255–1263
   PubMed Web of Science ®Google Scholar
• Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P., Gallo R. C. Release, uptake, and effects of extracellular human immunodeficency virus type 1 Tat protein on cell growth and viral transcription. Journal of Virology 1993; 67: 277–287
   PubMed Web of Science ®Google Scholar
• Ensoli B., Gendelman R., Markham P., Fiorelli V., Colomhini S., Raffeld M., Cafaro A., Chang H. K., Brady J. N., Gallo R. C. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994; 271: 674–680
   Google Scholar
• Ganju R. K., Munshi N., Nair B. C., Liu Z. -Y., Gill P., Groopman J. E. Human immunodeficency virus Tat modulates the Flk-I/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. Journal of Virology 1998; 72: 613–617
   Google Scholar
• Giuliani R., Bastaki M., Coltrini D., Presta M. Role of endothelial cell extracellular signal-regulated kinase1/2) in urokinase-type plasminogen activator upreguiation and in vitro angiogenesis by fibroblast growth factor-2. Journal of Cell Science 1999; 112: 2597–2606
   PubMed Web of Science ®Google Scholar
• LaValee T. M., Prudovsky J. A., McMahon G. A., Hu X., Maciag T. Activation of the MAP-kinase pathway by FGF-I correlates with cell proliferation while activation of the src pathways correlates with migration. Journal of Cell Biology 1998; 141: 1647–1658
   PubMed Web of Science ®Google Scholar
• Li C. J., Ueda Y., Shi B., Borodyansky L., Huang L., Li Y. -Z., Pardee A. B. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proceedings of the National Academy of Sciences U.S.A 1997; 94: 8116–8120
   PubMed Web of Science ®Google Scholar
• Kroll J., Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. Journal of Biological Chemistry 1997; 272: 32521–32527
   PubMed Web of Science ®Google Scholar
• Maroder M., Scarpa S., Screpanti I., Stigliano A., Meco D., Vacca A., Stuppia L., Frati L., Modesti A., Gulino A. Human immunodeficiency virus type 1 Tat protein modulates fibronectin expression in thymic epithelial cells and impairs in vitro thymocyte development. Cell Immunology 1996; 168: 49–58
   PubMed Web of Science ®Google Scholar
• Marshall C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179–185
   PubMed Web of Science ®Google Scholar
• Menengon A., Leoni C., Benfenati F., Valtorta F. Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum. Biochemical and Biophysical Research Communication 1997; 238: 800–805
   PubMed Web of Science ®Google Scholar
• McCarthy S. A., Kuzu I., Gatter K. C., Bicknell R. Heterogeneity of the endothelial cell and its role in organ preference of tumor metastasis. Trends in Pharmacological Sciences 1991; 12: 462–467
   PubMed Web of Science ®Google Scholar
• Milani D., Mazoni M., Borgatti P., Zauli G., Canlley L., Capitani S. Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells. Journal of Biological Chemistry 1996; 271: 22961–22964
   PubMed Web of Science ®Google Scholar
• Mitola S., Sozzani S., Luini W., Primo L., Borsatti A., Weich H., Bussolino F. Tat-human immunodeficency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood 1997; 90: 1365–1372
   PubMed Web of Science ®Google Scholar
• Ribatti D., Gualandris A., Bastaki M., Vacca A., Roncali L., Presta M. A new model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM): the gelatin sponge/CAM assay. Journal of Vascular Researches 1997; 34: 455–463
   PubMed Web of Science ®Google Scholar
• Rusnati M., Tulipano G., Spillmann D., Tanghctti E., Oreste P., Zoppetti G., Giacca M., Presta M. Multiple interaction of HIV-1 Tat protein with size-defined heparin oligosaccharides. Journal of Biological Chemistry 1999; 274: 28198–28205
   PubMed Web of Science ®Google Scholar
• Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C. -H. Different signal transduction properties of KDR and Fit-1, two receptors for vascular endothelial growth factor. Journal of Biological Chemistry 1994; 269: 26988–26995
   PubMed Web of Science ®Google Scholar
• Waltenberger J., Mayer U., Pentz S., Hombach V. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 1996; 94: 1647–1654
   PubMed Web of Science ®Google Scholar
• Wu L. -W., Mayo L. D., Dunbar J. D., Kessler K. M., Baerwald M. R., Jaffe E. A., Wang D., Warren R. S., Dormer D. B. Utilization of a distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. Journal of Biological Chemistry 2000; 275: 5096–5103
   PubMed Web of Science ®Google Scholar
• Yu Y., Sato J. D. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. Journal of Cellular Physiology 1999; 178: 235–246
   PubMed Web of Science ®Google Scholar